Technical Analysis for LIFE - aTyr Pharma, Inc

Grade Last Price % Change Price Change
grade B 6.04 23.27% 1.1400
LIFE closed up 23.27 percent on Tuesday, January 21, 2020, on 1.38 times normal volume. The bulls were able to push the stock to a new 52-week high.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical LIFE trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
New 52 Week High Strength 0.00%
Gapped Up Strength 0.00%
Up 3 Days in a Row Strength 0.00%
New 52 Week Closing High Bullish 23.27%
180 Bullish Setup Bullish Swing Setup 23.27%
New 52 Week High Strength 23.27%
Gapped Up Strength 23.27%
New 52 Week Closing High Bullish 64.58%
New 52 Week High Strength 64.58%
Older signals for LIFE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of medicines for the treatment of cancer and lung disease in the United States. The company's therapeutic candidate pipeline that includes ATYR1923 candidate, an agonist of the Resokine pathway that is in Phase I clinical trial designed to temper immune engagement in interstitial lung diseases; and ORCA program, a preclinical research stage program that targets immuno-oncology pathway using antibodies to enhance the immune response in tumor settings. It is also developing ATYR1940, a therapeutic candidate based on a protein naturally secreted from muscle for the treatment of facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and duchenne muscular dystrophy. aTyr Pharma, Inc. has collaboration with the University of Nebraska Medical Center to advance neuropilin-2 biology and therapeutic opportunities for ATYR1923. The company was founded in 2005 and is headquartered in San Diego, California.
Medicine Biotechnology Medical Specialties RTT Cancer Organ Systems Treatment Of Cancer Antibodies Tumor Cancer Immunotherapy Stage Biotechnology Muscular Dystrophy Duchenne Duchenne Muscular Dystrophy Dystrophy Lung Disease

Is LIFE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 6.74
52 Week Low 0.4852
Average Volume 163,691
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 2.3413
Average True Range 0.5048
ADX 0.0
+DI 86.0959
-DI 3.9295
Chandelier Exit (Long, 3 ATRs ) 5.2256
Chandelier Exit (Short, 3 ATRs ) 1.9996
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.8870
MACD Signal Line 0.3284
MACD Histogram 0.5587
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.1650
Resistance 3 (R3) 7.2733 7.0067 6.9775
Resistance 2 (R2) 7.0067 6.7202 6.9525 6.9150
Resistance 1 (R1) 6.5233 6.5432 6.3900 6.4150 6.8525
Pivot Point 6.2567 6.2567 6.1900 6.2025 6.2567
Support 1 (S1) 5.7733 5.9702 5.6400 5.6650 5.2275
Support 2 (S2) 5.5067 5.7932 5.4525 5.1651
Support 3 (S3) 5.0233 5.5067 5.1025
Support 4 (S4) 4.9150